News

Boehringer Ingelheim's IVOMEC® Gains EUA for Cattle Protection

Boehringer Ingelheim's IVOMEC® Gains EUA for Cattle Protection

Boehringer Ingelheim's New Tool for Cattle Protection

In a significant development for cattle producers, Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for IVOMEC® (ivermectin) 1% Injection. This product is designed to offer preventive measures against infestations caused by the New World screwworm (NWS) in cattle.

FDA's Landmark Decision

The issuance of the EUA represents a milestone as it is the first emergency authorization of an over-the-counter drug specifically for the purpose of preventing New World screwworm infestations in cattle. This preventive measure is critical, especially given the recent detections of NWS in livestock in Mexico, which underscore the need for readiness and access to effective solutions for livestock owners in the U.S.

Conditions for Use

The IVOMEC (ivermectin) 1% Injection is approved for use during crucial moments for cattle: within 24 hours of birth, at the time of castration, or when a wound is first noticed. However, it is important to note that the product is not authorized for use in female dairy cattle that produce milk for human consumption or in calves intended for veal production. The FDA has determined that there are no adequate, approved substitutes for this preventive treatment in these critical situations.

Protecting Livestock Health

Steve Boren, Vice President of U.S. Livestock at Boehringer Ingelheim, emphasized the company’s commitment to the health and welfare of livestock, stating, "Emergency Use Authorization for IVOMEC® provides cattle producers with a crucial preventive tool against New World screwworm. We appreciate the swift action of the FDA and USDA in combating this emerging threat to animal health, and we remain devoted to assisting veterinarians and producers during this critical time.”

The Impacts of New World Screwworm

The New World screwworm is a parasite that poses severe risks to the health of livestock, as its larvae can inflict catastrophic tissue damage and lead to fatal infestations. While NWS is not presently established in the United States, its recent appearance in northern Mexico serves as a dire warning. Awareness and proactive measures are essential to protecting herd health and safeguarding food supply chains.

Expert Insights on Prevention

Dr. Gustavo Sabatini, a Global Technical Manager at Boehringer Ingelheim, noted the critical importance of being prepared against NWS, having experience in regions where this threat is prevalent. He highlights the necessity for producers to have access to effective preventive measures. “Screwworm infestations typically occur at vulnerable stages in cattle's lives, and thus, prevention is crucial not only for animal health but for the livelihood of farmers and the safety of our food supply,” he stated.

Regulatory Framework for IVOMEC

The authorization of IVOMEC (ivermectin) 1% Injection remains valid as long as the FDA's declaration of emergency use continues. This means that the context surrounding its use must be continually monitored to ensure it aligns with prevailing regulations and safety standards.

Safety Information

It is important for users to be aware of essential safety guidelines associated with IVOMEC (ivermectin) 1% Injection. Treatment of cattle within 35 days of slaughter is prohibited. Additionally, the product should not be used on female dairy cattle of breeding age or veal calves due to safety concerns. The use in other animal species, which are not specified in the label, may also result in severe adverse reactions.

About Boehringer Ingelheim

Boehringer Ingelheim is a prominent force in animal health, dedicating extensive resources toward innovation in preventing and treating animal diseases. The company’s offerings include vaccines and treatment technologies aimed at promoting animal health across diverse species. As a leader in the field, Boehringer Ingelheim recognizes the strong interconnection between human and animal health, striving to contribute positively to the community and society at large.

Frequently Asked Questions

What is IVOMEC® (ivermectin) 1% Injection used for?

IVOMEC® is used to prevent infestations of New World screwworm in cattle during critical times such as shortly after birth or at the first sign of injury.

What authorization has the FDA granted for IVOMEC?

The FDA issued Emergency Use Authorization for IVOMEC® to provide a preventive measure against NWS infestations in cattle.

Why is the New World screwworm a concern?

The New World screwworm can severely damage livestock by feeding on living tissue, leading to painful conditions and potentially fatal outcomes.

Are there any restrictions on using IVOMEC?

Yes, IVOMEC should not be used on female dairy cattle producing milk for humans or on calves intended for veal.

How does Boehringer Ingelheim contribute to animal health?

Boehringer Ingelheim focuses on research and innovation to develop treatments and vaccines aimed at improving livestock health, thereby ensuring a safer food supply.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 56

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 69

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 74

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 55

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 51

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 59

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 65

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

M/I Homes Achieves Record Earnings in Recent Financial Report

Updated Category News Views 78

Strong Financial Performance in Q3 2024 M/I Homes, Inc. (NYSE: MHO) has reported impressive results for its third quarter of the 2024 fiscal year. The company achieved record homes delivered, revenue, and income in a highly competitive market. During this period, M/I Homes delivered 2,271 homes, reflecting an 8% increase compared to the previous year. The total revenue...

Continue Reading
McKesson Corporation Set to Release Earnings This November

Updated Category News Views 58

McKesson Corporation's Second Quarter Earnings Announcement McKesson Corporation (NYSE: MCK) is preparing to release its earnings report for the second quarter of fiscal 2025, which will happen after the market closes. Investors and stakeholders can expect to see the detailed financial results made public on a Wednesday. This announcement is a significant moment for the...

Continue Reading
GTCR's Strategic Shift: Worldpay Sold to Global Payments

Updated Category News Views 1118

GTCR Sells Worldpay to Global Payments for $24.25 Billion In a major development shaking the financial technology landscape, GTCR, a prominent private equity firm, has officially entered into an agreement to sell Worldpay, a key player in payments processing, to Global Payments for a staggering $24.25 billion. This decisive move highlights GTCR’s strategic...

Continue Reading
Koning Health's Series C Fundraising Fuels Breast Imaging Innovation

Updated Category News Views 236

Koning Health's Series C Funding Initiative Koning Health, a leading name in medical imaging, has officially announced the commencement of its Series C fundraising. This strategic move is being executed in collaboration with Sage Tap Poder SPV, aiming to enhance the reach and capabilities of the innovative Koning Vera Breast CT system. Transforming Breast Imaging...

Continue Reading
YY Group and Obita Collaborate for a Seamless Payment Future

Updated Category News Views 133

YY Group Forges Partnership with Obita for Payment Innovation YY Group Holding Limited (Nasdaq: YYGH) has embarked on an exciting journey, teaming up with Obita, an enterprise-level cross-border payment and digital financial network based in Singapore. This collaboration, formalized through a Memorandum of Understanding (MOU), aims to revolutionize the payment landscape...

Continue Reading